OnKure Therapeutics, Inc. (OKUR)
2.37
-0.16
(-6.14%)
USD |
NASDAQ |
Nov 06, 10:06
OnKure Therapeutics Debt to Equity Ratio : 0.005 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.005 |
| June 30, 2026 | 0.0054 |
| March 31, 2026 | 0.0022 |
| December 31, 2025 | 0.0098 |
| September 30, 2025 | 0.0103 |
| June 30, 2025 | 0.0105 |
| March 31, 2025 | 0.0105 |
| December 31, 2024 | 0.0104 |
| September 30, 2024 | 0.009 |
| June 30, 2024 | 0.0107 |
| March 31, 2024 | 0.0112 |
| December 31, 2023 | 0.0241 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0099 |
| June 30, 2023 | 0.0092 |
| March 31, 2023 | 0.0154 |
| December 31, 2022 | 0.0146 |
| September 30, 2022 | 0.0121 |
| June 30, 2022 | 0.0118 |
| March 31, 2022 | 0.0117 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -2.875 |
| December 31, 2020 | -2.202 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Heron Therapeutics, Inc. | 21.48 |
| Tonix Pharmaceuticals Holding Corp. | 0.0057 |
| Karyopharm Therapeutics, Inc. | -0.7759 |
| Minerva Neurosciences, Inc. | -0.3363 |
| Corbus Pharmaceuticals Holdings, Inc. | 0.0417 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 167.08M |
| Total Liabilities (Quarterly) | 9.34M |
| Shareholders Equity (Quarterly) | 157.74M |
| Current Ratio | 18.84 |
| Net Debt Paydown Yield | 0.01% |